Build stable, high-performance dashboards using REPT formulas and UNICHAR symbols instead of conditional formatting.

Power Pivot excels in handling large datasets and performing complex analytics, using data modeling and DAX expressions, but ...

BYROW replaces thousands of table formulas with one spill formula, making spreadsheets leaner and much more robust.

It may be a surprise to learn that you can define names of cells in Microsoft Excel instead of using the letter and number combinations. This makes it friendlier to read and understand. For example, ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

There is more to Formula 1 than its swift speeds. Behind these thrilling races are integral parts and mechanics that come at a staggering price, all for the sake of victory. Normal cars can be ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...